HealthcareServices

Atrial Fibrillation Market Forecast 2026–2035: Data Trends and Industry Insights

February 23, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the atrial fibrillation market from 2026–2035 with trusted insights from The Business Research Company

By how much is the Atrial Fibrillation Market expected to grow between 2026 and 2030?

The atrial fibrillation market size has seen swift expansion in recent years. This market is expected to increase from $15.1 billion in 2025 to $17.1 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 13.2%. The historical growth trajectory can be attributed to several factors, including the rising prevalence of atrial fibrillation among older demographics, enhanced access to cardiac diagnostic technologies, broader availability of anticoagulant therapies, the proliferation of electrophysiology laboratories, and an increased understanding of stroke prevention.

The atrial fibrillation market is projected to experience significant expansion in the coming years, reaching a valuation of $27.88 billion by 2030, driven by a compound annual growth rate (CAGR) of 13.0%. This anticipated growth during the forecast period is fueled by several factors, including the surging demand for individualized arrhythmia treatments, the increasing uptake of wearable devices for cardiac monitoring, the broadening scope of hybrid treatment methods, rising investments in electrophysiology infrastructure, and an enhanced emphasis on achieving long-term rhythm management results. Key developments anticipated in this period encompass the growing acceptance of catheter ablation procedures, the greater utilization of sophisticated cardiac mapping systems, a stronger inclination towards minimally invasive therapies, the proliferation of pharmacological rhythm control treatments, and a heightened focus on timely diagnosis and monitoring.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8007&type=smp

Which Drivers Are Influencing Market Acceleration In The Atrial Fibrillation Market?

The escalating incidence of cardiovascular diseases is anticipated to propel the atrial fibrillation market ahead. These disorders, which pertain to the heart and blood vessels and include conditions like coronary artery disease, heart failure, and arrhythmias, pose a considerable threat to overall cardiovascular health. The increasing number of cardiovascular conditions emphasizes a growing demand for advanced diagnostic and treatment solutions, thus driving the atrial fibrillation market as healthcare providers and industries respond to the mounting difficulties presented by the rising occurrence of these illnesses. For instance, in October 2024, the CDC, a U.S.-based government agency, indicated that 919,032 people died from cardiovascular disease in 2023, which equates to 1 in every 3 deaths. Moreover, around 805,000 people in the United States suffer a heart attack annually. Therefore, the substantial global burden of cardiovascular diseases will be a significant driver for the atrial fibrillation market.

What Leading Segments Are Studied In The Atrial Fibrillation Market?

The atrial fibrillation market covered in this report is segmented –

1) By Type: Surgical, Non-Surgical

2) By Technology: Radiofrequency, Laser, Cryotherapy, Other Technologies

3) By Treatment Type: Pharmacological Treatment, Non-pharmacological Treatment, Maze Surgery, Electric Cardioversion

4) By End User: Hospitals, Electrophysiology Labs, Ambulatory Surgical Centers

Subsegments:

1) By Surgical: Catheter Ablation, Maze Procedure, Hybrid Ablation Procedures

2) By Non-Surgical: Antiarrhythmic Drugs, Anticoagulants, Cardioversion Procedures

What Trends Are Reshaping The Dynamics Of The Atrial Fibrillation Market?

Leading companies within the atrial fibrillation market are introducing innovative offerings, including patient-focused clinical decision support tools, to enhance their standing. These clinical decision support tools (CDST) are software or electronic systems crafted to empower healthcare professionals in making well-informed and prompt patient care decisions. Such tools are designed to consolidate pertinent clinical data from diverse origins. For example, in August 2023, GE HealthCare, a US-based multinational medical technology firm, introduced CardioVisio. This patient-centered clinical decision support tool aims to help physicians implement evidence-based clinical decisions guided by current atrial fibrillation guidelines and to display longitudinal data from various sources relevant to disease advancement. Specifically for atrial fibrillation, CardioVisio can aid cardiologists by simplifying the interpretation of clinical images and by presenting a comprehensive view of a patient’s cardiac history and overall healthcare journey, encompassing prior diagnoses, prescribed medications, interventions, and coexisting conditions.

Which Leading Companies Dominate The Atrial Fibrillation Market Share?

Major companies operating in the atrial fibrillation market are AtriCure Inc, Abbott Laboratories, Medtronic PLC, Boston Scientific Corporation, Johnson & Johnson, Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Company, Sanofi SA, Bayer AG, Pfizer Inc, Daiichi Sankyo Company Limited, AstraZeneca PLC, Biotronik SE & Co KG, Kardium Inc, Acutus Medical Inc, Apama Medical Inc, CardioFocus Inc, AliveCor Inc, iRhythm Technologies Inc, BioSig Technologies Inc

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/atrial-fibrillation-global-market-report

How Does The Atrial Fibrillation Market Perform Across Major Global Regions?

North America was the largest region in the atrial fibrillation market in 2025. Asia-Pacific is expected to be the fastest-growing region in the atrial fibrillation market report forecast period. The regions covered in the atrial fibrillation market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Atrial Fibrillation Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=8007&type=smp

Browse Through More Reports Similar to the Global Atrial Fibrillation Market 2026, By The Business Research Company

Atrial Septal Defect Market Report 2026

https://www.thebusinessresearchcompany.com/report/atrial-septal-defect-global-market-report

Ventricular Fibrillation Market Report 2026

https://www.thebusinessresearchcompany.com/report/ventricular-fibrillation-global-market-report

Arrhythmia Market Report 2026

https://www.thebusinessresearchcompany.com/report/arrhythmia-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795